Introduction
============

Alkylating compounds represent one of the most abundant classes of mutagenic and genotoxic agents present in the environment. 7-methylguanine (7mG), 3-methyladenine (3mA), 3-methylguanine (3mG), O^6^-methylguanine (O^6^mG) and 1-methyladenine (1mA) are major base modifications introduced by methylating agents. While O^6^mG and 1mA are repaired by direct reversal of the damage, involving a DNA alkyltransferase or the iron-2-oxoglutarate dependent AlkB protein respectively ([@b21]; [@b50]), 3mA and other N-alkylated purines are excised from the DNA by base excision repair (BER) ([@b46]). The first step of BER is mediated by a DNA glycosylase hydrolysing the N-glycosylic bond thus releasing the damaged base in a free form and creating an abasic (AP) site in the DNA. The AP site is incised at the 5′-side or the 3′-side by an AP endonuclease or an AP lyase respectively. The repair is completed by a DNA phosphodiesterase cleansing the ends, a DNA polymerase filling the gap of one to several nucleotides and finally a DNA ligase seals the nick ([@b47]; [@b22]).

DNA glycosylases removing alkylated base residues have been identified in all organisms investigated and may be universally present in nature. As 3mA is a main substrate for these enzymes, they are generally referred to as 3mA DNA glycosylases. *Escherichia coli* possesses two enzymes of this type, 3mA DNA glycosylase I (Tag) which is constitutively expressed ([@b24]), and 3mA DNA glycosylase II (AlkA) which is induced by cell exposure to alkylating agents ([@b39]; [@b19]). The Tag enzyme has a rather narrow substrate specificity, limited to 3mA and 3mG ([@b8]), whereas AlkA is a much more versatile enzyme and removes 3mA, 3mG, 7mG, O2-methylpyrimidines, hypoxanthine, ethenoadenine and thymine residues oxidized in the methyl group ([@b19]; [@b25]; [@b27]; [@b9]; [@b42]; [@b43]). The methyl group of 7mG protrudes into the major groove of the double-helix and does not appear to cause mutations or block DNA replication. In contrast, both 3mA and 3mG are minor groove lesions and represent blocks to DNA replication because of impaired stacking properties. These lesions therefore have severe cytotoxic effects and need to be removed prior to DNA replication ([@b10]; [@b26]).

The Tag and AlkA proteins share no significant sequence homology in spite of their functional similarity. The 3mA DNA glycosylases from *Saccharomyces cerevisiae* (Mag) and *Schizosaccharomyces pombe* (Mag1) both belong to the AlkA family, whereas the mammalian enzymes (Aag) are different with little or no relevant sequence homology and hence represent a third family of 3mA DNA glycosylases. This family was initially thought to be limited to mammalian cells, but genome sequencing efforts have revealed the presence of homologous proteins in certain prokaryotic species as well ([@b1]). Some enzymes of the endonuclease III (Nth) family of DNA glycosylases remove methylated purines from DNA and constitute a forth family of 3mA DNA glycosylases ([@b4]; [@b34]).

Mutants of *E. coli* lacking both Tag and AlkA are extremely sensitive towards exposure to simple alkylating agents such as methyl methanesulphonate (MMS) and dimethylsulphate. Functional complementation of the *tag alkA* double mutant with a gene expressing 3mA DNA glycosylase activity will restore alkylation resistance. Such mutants have been instrumental for the cloning of 3mA DNA glycosylase genes from other organisms, including *Micrococcus luteus* ([@b35]), yeast ([@b12]; [@b5]; [@b28]), *Arabidopsis thaliana* ([@b41]) and mammalian cells ([@b11]; [@b32]; [@b33]; [@b40]; [@b18]). The same approach was utilized in this study to screen for 3mA DNA glycosylases in *Bacillus cereus*, which is a soil bacterium that is heavily exposed to methylating agents such as methylchloride under normal life conditions ([@b51]). Three different genes were recovered, termed *alkC, alkD* and *alkE,* which complemented the MMS sensitivity of the *E. coli tag alkA* double mutant. AlkC and AlkD represent novel genes with no homology to previously characterized DNA glycosylases. We purified both enzymes to homogeneity and found that AlkC and AlkD indeed are functional 3mA DNA glycosylases. Iterative searches of the Non-redundant Protein Sequence Database (NCBI) revealed that AlkC and AlkD are distant homologues belonging to a new superfamily of proteins.

Results
=======

Three open reading frames of *B. cereus* genome that complement the alkylation-sensitive phenotype of the E. coli strain BK2118 (*tag alkA*)
--------------------------------------------------------------------------------------------------------------------------------------------

The alkylation repair-defective *E. coli* strain *BK2118*, which is lacking the AlkA and Tag 3mA DNA glycosylases, was transformed by different genome libraries made either from DNA isolated from the *B. cereus* strain ATCC 10987 or from commercially available *B. cereus* DNA (Promega, non-determined strain). Transformants surviving on media containing MMS were isolated, and plasmids were analysed by DNA sequencing and restriction cleavage. The DNA sequences were assembled into three complete open reading frames (ORFs) termed AlkC (Promega), AlkD (Promega) and AlkE (ATCC 10987). Next, three selected clones containing *alkC, alkD* or *alkE* were re-transformed into *BK2118* and plated on media containing increasing amounts of MMS. Full rescue was obtained with plasmids expressing AlkC, AlkE and *E. coli* AlkA (control), whereas AlkD was partially complementing the MMS sensitivity of *BK2118*([Fig. 1](#fig1){ref-type="fig"}). Furthermore the capability of AlkC, AlkD and AlkE to remove alkylated bases was examined in cell extracts prepared after expression of the three enzymes in BK2118 with calf thymus DNA treated with N-\[^3^H\]-methyl-*N*-nitrosourea as substrate. Excision of methylated bases was confirmed in all three extracts, whereas similar extracts from cells containing the pUC19 vector without insert showed no removal of methylated bases ([Fig. 2](#fig2){ref-type="fig"}). It thus appears that all three *B. cereus* enzymes possess alkylbase DNA glycosylase activity*.*

![MMS survival of BK2118 (*alkA tag*) transformed by *B. cereus* clones pUC-*alkC*, pUC-*alkD* and pUC-*alkE*. Logarithmically growing BK2118 cells harbouring expression constructs for AlkA (◊), AlkC (▴), AlkD (▪), AlkE (×) or pUC (□) only were spread on LB plates containing 0.5, 1, 2 or 5 mM MMS and incubated at 37°C for 2 days. The percentage of surviving colonies was calculated. This survival experiment was repeated three times with similar results.](mmi_5044_f1){#fig1}

![3mA DNA glycosylase activity in protein extracts of *E. coli* BK2118 cells expressing *B. cereus* AlkC, AlkD or AlkE. \[^3^H\]-methyl-N-nitrosourea treated calf thymus DNA (800 fmol modified bases) was incubated with 1 µg extracts at 37°C for 30 min, the DNA was ethanol precipitated and the supernatant subjected to scintillation counting. Control cells contained empty pUC vector.](mmi_5044_f2){#fig2}

AlkC and AlkD both belong to the same protein superfamily
---------------------------------------------------------

The deduced amino acid sequences were compared with protein sequences in the NCBI non-redundant protein database (see Table S1 for accession numbers). The *alkE* gene encoded a putative protein of 287 amino acids with 26% identity and 45% similarity to the *E. coli* AlkA protein over an aligned region of 170 amino acids (Fig. S1). The nucleotide sequence of *alkC* and *alkD* translates into polypeptides of 256 and 237 amino acids respectively. Iterative sequence similarity searches using [psi]{.smallcaps}-[blast]{.smallcaps} in the NCBI non-redundant protein sequence database showed that homologues of both AlkC and AlkD are present in several prokaryotic organisms; however, none of these were annotated as DNA repair enzymes or other proteins with known function (Figs. S2 and S3). Further analysis of the iterative searches revealed that many of the members of the AlkC group were also present in the AlkD group and vice versa indicating that AlkC and AlkD are distant homologues belonging to a large superfamily of uncharacterized proteins. For example, alignment of homologues from *Pasteurella multocida* and uncultured archea GZfos12E1 with *B. cereus* AlkC and AlkD demonstrate the link between the two families (Fig. S4). Other examples of organisms with AlkC and AlkD homologues include: firmicutes (*Bacillus subtilis*), proteobacteria (*Agrobacterium tumefaciens, Helicobacter hepaticus* and *Pseudomonas* sp.), planctomycetes (*Rhodopirellula baltica*), proteobacteria, actinobacteria, bacteroidetes, archaeon and spirochaetes (*Leptospira* sp.). Cyanobacteria appear to be the only bacterial group without ORFs with sequence similarity to AlkC and AlkD. It thus appears that the AlkC/AlkD superfamily is widespread in prokaryotes. *Entamoeba histolytica* and *Dictyostelium discoideum,* which are protezoa causing amebic dysentery, seem to be the only eukaryotes yet found to harbour this protein family.

Removal of alkylated bases by AlkC and AlkD
-------------------------------------------

To investigate the enzymatic properties of AlkC and AlkD proteins in more detail, the coding sequences were subcloned in the expression vector pT7-SCII and the proteins were produced in *E. coli* strain BL21. Both AlkC and AlkD were purified to near physical homogeneity by a three-step procedure including AffiGel Blue, MonoQ and DNA cellulose chromatography. AlkC and AlkD migrate on SDS-PAGE as proteins of 28 kDa and 25 kDa respectively, which is in good agreement with the molecular weights calculated from the amino acid sequence (29.9 and 28.2 kDa respectively).

We examined the abilities of the purified AlkC and AlkD enzymes to remove alkylated bases by using DNA treated with N-\[^3^H\]-methyl-*N*-nitrosourea as substrate and separation of the radiolabelled excision products by high-performance liquid chromatography (HPLC) ([Fig. 3](#fig3){ref-type="fig"}). The amounts of methylpurines formed in such DNA are 65% 7mG, 10% 3mA and 0.7% 3mG ([@b8]). From these measurements it appears that AlkD has a high activity towards 7mG ([Fig. 3C](#fig3){ref-type="fig"}), but removes 3mG more slowly as compared with *E. coli* AlkA ([Fig. 3B](#fig3){ref-type="fig"}). 3mA is excised at a comparable rate for AlkD and *E. coli* AlkA ([Fig. 3A](#fig3){ref-type="fig"}). AlkC is more efficient in removing 3mA as compared with *E. coli* AlkA ([Fig. 3A](#fig3){ref-type="fig"}), whereas excision of 3mG proceeds at a similar rate ([Fig. 3B](#fig3){ref-type="fig"}). Further, AlkC shows only limited removal of 7mG ([Fig. 3C](#fig3){ref-type="fig"}), and appears to be essentially 3-methylpurine specific. AlkC therefore compares with the Tag enzyme from *E. coli* in its specificity for 3-methylpurines, except that the efficiency of 3mG removal is much higher than for Tag. AlkC and AlkD thus appear to functionally complement each other by efficiently removing the major N-alkylated purine products in alkylated DNA. Furthermore, inefficient removal of the cytotoxic 3mG lesion by AlkD ([Fig. 3B](#fig3){ref-type="fig"}) could explain why expression of AlkD in *alkA tag E. coli* mutant cells does not restore the alkylation resistance completely ([Fig. 1](#fig1){ref-type="fig"}).

![Reverse phase HPLC of methylated bases released by AlkA, AlkC and AlkD from \[^3^H\]-methyl-*N*-nitrosourea treated calf thymus DNA. \[^3^H\]-MNU-DNA was incubated with increasing amounts of AlkA (◊), AlkC (▪) and AlkD (•) at 37°C for 30 min. The DNA was precipitated with ethanol and the supernatant was analysed by HPLC. Radioactivity in fractions corresponding to 3mA (A), 3mG (B) and 7mG (C) was measured in a liquid scintillation counter. The experiments in this figure were repeated three times with similar results.](mmi_5044_f3){#fig3}

Several 3mA DNA glycosylases have been reported to be active against a broad range of lesions including deaminated and oxidized bases. The mammalian Aag and *E. coli* AlkA DNA glycosylases excise pre-mutagenic lesions such as deaminated adenine (hypoxanthine) ([@b42]) and cyclic etheno adducts (1, *N*^6^-ethenoadenine and 1, *N*^2^-ethenocytosine ([@b15]). Furthermore, mammalian Aag was reported to remove oxidized guanine, 7, 8-dihydro-8-oxoguanine (8oxoG) ([@b6]) whereas *E. coli* AlkA are removing methyl-oxidized thymines (5-formyluracil and 5-hydroxymethyluracil) ([@b9]). The specificity of AlkC and AlkD towards hypoxanthine, 1,*N*^6^-ethenoadenine, 8oxoG and 5-formyluracil was examined on oligonucleotides containing a single lesion. Neither AlkC nor AlkD showed any detectable affinity for these DNA base lesions (data not shown). In addition, AlkC and AlkD showed no activity towards other important base lesions such as methyl-formamidopyrimidine and adenine mismatch (A:G). Finally, it was shown that AlkC and AlkD were not associated with an AP lyase activity when assayed with a double-stranded ^32^P-labelled oligonucleotide containing a single AP site. From these data it seems evident that the AlkC and AlkD are involved exclusively in the repair of alkylation damage in *B. cereus*.

Discussion
==========

In this work genomic libraries of *B. cereus* were screened by functional complementation of the alkylation sensitivity of the *E. coli tag alkA* mutant to identify 3mA DNA glycosylases. By this approach two novel ORFs, termed AlkC and AlkD, were identified encoding 3mA DNA glycosylases. Amino acid sequence analysis of AlkC and AlkD revealed no sequence homology to known DNA repair enzymes or other proteins with known function. Furthermore, similarity searches of the NCBI non-redundant database with the [psi]{.smallcaps}-[blast]{.smallcaps} program showed that the AlkC and AlkD families are ubiquitous in prokaryotic organisms. Moreover, searches initiated with AlkC or AlkD revealed several common ORFs, indicating that AlkC and AlkD belong to the same superfamily and have a common ancestral origin. Biochemical characterization was performed with purified AlkC and AlkD and compared with *E. coli* AlkA. Both AlkC and AlkD remove the major cytotoxic alkylation product 3mA efficiently, whereas the minor cytotoxic 3mG adduct is less efficiently removed by AlkD as compared with AlkC and *E. coli* AlkA. Several 3mA DNA glycosylases, including mammalian Aag and *E. coli* AlkA, remove pre-mutagenic base lesions such as deaminated adenine (hypoxanthine) and cyclic etheno adducts; however, AlkC and AlkD showed no activity towards these lesions. It thus appears that AlkC and AlkD are specific for removal of alkylated bases.

The activity of AlkD towards 7mG is substantially different from other alkylation repair activities so far described. The enzyme specificity for 7mG is surprising in the view of the notion that 7mG is supposed to be an innocuous lesion. It could be that 7mG removal is important to prevent possible interference caused by 7mG in protein/DNA interactions or to avoid the formation of secondary derivatives of 7mG. Alkylation of guanine at the N^7^ position will destabilize the N-glycosylic bond and promote spontaneous release of base residues resulting in the formation of cytotoxic and pre-mutagenic AP sites. Glycosylase removal of the base is likely to be more advantageous than spontaneous release because this will result in rapid completion of the BER pathway in a controlled manner ([@b46]). 7mG can also be converted by imidazole ring opening to a formamidopyrimidine residue, which is a strong cytotoxic lesion ([@b10]), and removal of 7mG will limit such conversion.

The substrate specificity of AlkC is similar to *E. coli* Tag which showed no significant affinity for 7mG and efficient excision of 3mA ([@b8]). However, in contrast to Tag, AlkC removes 3mG with high efficiency. This may be of advantage to an organism being exposed to high levels of alkylation where the formation of 3mG may be substantial, even though the relative rate of formation is low. It is clear from studies of *E. coli* that the Tag enzyme is essential for the first protection against sudden exposure to alkylation before the adaptive response is turned on ([@b19]; [@b44]). *B. cereus* also has an adaptive response to alkylation ([@b29]) and the *alkC* gene may serve a similar function in *B. cereus* as *tag* in *E. coli*.

*Bacillus* sp. are aerobic, endospore-forming, Gram positive rods widely distributed in soil, air and water and may be heavily exposed to alkylating agents such as methylchloride. Our data could support that *Bacillus* have special requirements for repair of alkylated DNA. Several *Bacillus* sp., including *B. cereus, Bacillus anthracis* and *Bacillus thuringiensis,* appear to contain as much as five different 3mA DNA glycosylases (Table S2). For example, the *B. cereus* strains ATCC 14579, E33L and G9241 contains in addition to AlkC and AlkD, two ORFs with homology to AlkA and one putative Aag glycosylase. [@b29] have shown that the overall level of 3mA DNA glycosylase activity in *B. cereus* is enhanced by treatment with low doses of alkylating agents, suggesting a DNA damaging inducible response similar to the adaptive response in *E. coli*. Genome sequence analysis showed that the *alkA* and *ada* operons of the adaptive response are conserved in *B. cereus* ([@b29]), indicating that the putative AlkA homologues of the *alkA* operons could be inducible. The complex life cycle of *Bacillus* may also require more pathways for maintaining genome stability. In the spores of *B. subtilis* a specific repair process for reversal of photoproducts has been identified ([@b20]) and repair of alkylated bases may also be necessary in spores.

DNA glycosylases is classified based on biochemical features and similarity in amino acid sequence and three-dimensional structure. One superfamily of DNA glycosylases, which is characterized by the helix hairpin helix (HhH) motif, comprises several families with different substrate specificities. For example, *E. coli* AlkA, Nth1 and MutY remove alkylated bases, oxidized pyrimidines and adenine mismatches respectively. Therefore, we may speculate if the AlkC/AlkD superfamily possesses DNA glycosylase activities with specificities towards a broader spectrum of base lesions including oxidized and deaminated bases.

Experimental procedures
=======================

Bacterial strains, plasmid vectors, gene libraries and growth conditions
------------------------------------------------------------------------

DNA libraries were constructed using DNA isolated from *B. cereus* ATCC 10987, obtained from the American Type Culture Collection or by using DNA obtained from Promega. The Promega DNA was originally marketed as being from the yeast *S. pombe*; however, further analysis of this DNA by 16S RNA DNA sequencing and hybridization analysis revealed that the DNA purchased indeed was from *B. cereus*. The *alkC* and *alkD* genes were isolated from the Promega DNA and the *alkE* gene from ATCC 10987. Cloning vectors pUC18 and pUC19 were used for construction of libraries and for subcloning.

*Escherichia coli* strains DH5α and BL21 were used as recombinant hosts. The DNA glycosylase-deficient strain *E. coli* BK2118 (*tag*, *alkA*) described by [@b13] was used for the complementation screening. Clones complementing the alkylation-sensitive phenotype of BK2118 were selected on Luria--Bertani (LB) agar containing 1, 3 or 5 mM MMS. From isolated colonies plasmids were isolated and checked for complementation by a second round of transformation and testing for MMS resistance. All bacteria were grown in LB broth or on LB agar at 37°C. Ampicillin was used at a concentration of 50 µg ml^−1^, where appropriate.

DNA sequencing and sequence analysis
------------------------------------

Sequence analysis was performed using the Geneting program (Lillestrom, Norway) and the GCG Sequence Analysis Software ([@b14]). Homology searches were carried out using [salsa]{.smallcaps} ([@b38]), [paralign]{.smallcaps} ([@b37]), [blast]{.smallcaps} and [psi]{.smallcaps}-[blast]{.smallcaps} ([@b3]). Multiple sequence alignments were created using [clustal w]{.smallcaps} ([@b48]), [t]{.smallcaps}-[coffee]{.smallcaps} ([@b31]) and [muscle]{.smallcaps} ([@b17]). Alignment graphics were produced using [genedoc]{.smallcaps} ([@b30]) and [clustal x]{.smallcaps} ([@b49]). Accession numbers for AlkC, AlkD and AlkE for EMBL, UniProt and GenBank are given in Table S1.

Alkylation survival of BK2118 (*tag*, *alkA*) and transformed derivatives
-------------------------------------------------------------------------

*Escherichia coli* BK2118 transformed by expression constructs for the different alkylbase DNA glycosylases were grown in LB to an OD of 1.0--1.2, incubated on ice for 2--3 h, diluted in M9 buffer and spread on LB plates containing MMS at the concentrations indicated. Plates were incubated at 37°C for 2 days and the number of surviving cells was counted. The AlkA plasmid was pBK161 ([@b23]).

Expression and purification of AlkC and AlkD
--------------------------------------------

The *alkC* containing fragment (1347 bp; *alkC* ORF 771 bp) was excised from the pUC-*alkC* plasmid by cleavage with EcoRI and PstI, and reinserted at the corresponding restriction sites of the expression vector pT7-SCII (Stratagene) to yield pT7-*alkC*. The AlkD coding region (714 bp) was PCR amplified with primers gcggatccc**ATG**CATCCATTTGTAA AAGCA (BamHI hinge in lower case and start codon in bold) and cccaagcttAAGTCCGTCATCGCTAC (HindIII hinge in lower case) from the pUC19 construct and inserted into pT7-SCII to yield pT7-*alkD*. The NdeI--BamHI fragment of the polylinker of pT7-*alkD* was removed to shorten the distance between the ribosomal binding site and the start codon. The correct sequence of both constructs was verified by DNA sequencing.

*Escherichia coli* strain BL21 harbouring pT7-*AlkD* plasmid was grown in LB medium (10 l) to an OD~600~ of 0.7. The culture was induced with IPTG (0.1 mM) for 2 h at 37°C and cell extract was prepared by a combination of plasmolysis and lysozyme treatment as previously described ([@b45]). To monitor AlkD purification, 3mA DNA glycosylase activity was measured by the method of [@b36] as modified ([@b7]). Cell extract was applied to an Affigel Blue (Bio-Rad) column (2 × 8 cm) equilibrated with buffer A (0.1 M Tris HCl, pH 8.0, 1 mM EDTA, 20% glycerol, 10 mM β-mercaptoethanol). After washing, active fractions were eluted with buffer A containing 1 M KCl. Fractions with alkylbase activity were pooled, dialysed against buffer A and applied to a MonoQ column (HR 5/5; Pharmacia). The column was eluted by a 0--2.0 M NaCl linear gradient in buffer A and peak fractions eluting between 0.2 and 0.3 M NaCl were pooled. Active fractions were diluted 1:4 in buffer A and applied to a calf thymus DNA cellulose column (HR 5/5; Pharmacia). The column was eluted with a linear gradient of 0--1.0 M KCl in buffer A and purified AlkD eluted at 0.25 M KCl.

AlkC was also expressed in *E. coli* BL21 and purified by a protocol similar to that used for AlkD. Extract made from 10 l culture was applied to an Affigel Blue column equilibrated with buffer A and eluted with 2 M KCl. Active fractions were pooled, dialysed against buffer A and applied to a MonoQ column. AlkC was collected in the flow-through and applied to a DNA cellulose column. The column was eluted with a linear gradient of 0--1.2 M KCl in buffer A and peak fractions eluted at 0.3 M KCl. The DNA cellulose chromatography was repeated to remove minor impurities.

Notably, *E. coli* AlkA and Tag showed no affinity to Affigel blue. Consequently, contaminations of endogenous 3mA DNA glycosylases were excluded during purification of AlkC and AlkD.

HPLC analysis of alkylated base derivatives
-------------------------------------------

Reverse phase HPLC of methylated bases released by the purified glycosylases was performed as described by [@b8]. Briefly, 2.5 µg DNA (15 000 dpm µg^−1^) of calf thymus DNA alkylated with N-\[^3^H\]-methyl-*N*-nitrosourea (1.5 Ci mmol^−1^; NET-408, Du Pont NEN) was incubated with different amounts of enzymes as indicated for 30 min at 37°C. The DNA was precipitated with ethanol, the supernatant concentrated by lyophilization and mixed with unlabelled alkylated bases as markers. The samples were analysed by HPLC (Spheri-5 RP-18, 220 × 4.6 mm, Brownlee Laboratories) using a linear gradient of 100--75% (v/v) 0.1 M triethylammoniumacetate buffer pH 7.3 or pH 5.4 in methanol for elution (1 ml min^−1^). Fractions of 0.5 ml were collected and the radioactivity was measured in a liquid scintillation counter. At pH 7.3, 3mG was well separated from 3mA and 7mG whereas pH 5.4 gave good separation of 7mG from the two 3-methyl purines. The reference compounds 3mA, 3mG and 7mG were from Fluka.

DNA substrates and enzyme assays
--------------------------------

The AP site-, 8oxoG- and faPy-containing DNA was prepared as described by [@b2] and 5-formyluracil and 5-hydroxymethyluracil substrates as described by [@b9]. The hypoxanthine-containing DNA substrate was a 25-mer oligonucleotide with hypoxanthine at position 13 ([@b2]). The A/G mismatch substrate was identical to the hypoxanthine-containing oligonucleotide except for the substitution of an adenine for hypoxanthine. All enzyme activities were assayed as described ([@b2]).
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**Fig. S1.** Sequence alignment of *B. cereus* AlkE and *E. coli* AlkA.

**Fig. S2.** Multiple sequence alignment of *B. cereus* AlkC and selected homologues.

**Fig. S3.** *Bacillus cereus* AlkD and selected homologues.

**Fig. S4.** Sequence alignment of *B. cereus* AlkC (top) and AlkD (bottom) and selected 'stepping stone' proteins that link them together.

**Table S1.** Accession numbers of AlkC, AlkD and AlkE.

**Table S2.** 3mA DNA glycosylases in different strains of *B. anthracis*, *B. thuringiensis* and *B. cereus* indicated by accession numbers, and classified by sequence homology to the AlkA, AlkC, AlkD and Aag family.
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